Page 3 of 4 · 82 questions tagged muscle-loss.
The case in front of me: survodutide · PIONEER-4. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a…
What I have: cagrilintide · SURMOUNT-2. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
Stated plainly: dulaglutide · STEP 3. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline. I do…
What I am working with: dulaglutide · ESSENCE. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
Setup, so nobody has to ask: retatrutide · SURMOUNT-5. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
Details up front: mazdutide · FLOW. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
What I have: mazdutide · SURMOUNT-1. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
What I am working with: dulaglutide · PIONEER-1. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
The particulars: oral semaglutide · SURMOUNT-3. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
What I am working with: orforglipron · SURPASS-3. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
Details up front: cagrilintide · ATTAIN-1. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
Numbers first: cagrilintide · STEP 8. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
Concretely: semaglutide · STEP 3. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics change…
What I am working with: dulaglutide · TRIUMPH-1. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
The case in front of me: ecnoglutide · ESSENCE. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
Numbers first: mazdutide · STEP 3. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
The case in front of me: ecnoglutide · SURMOUNT-5. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a…
Conditions: ecnoglutide · ATTAIN-1. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result,…
The specifics, since they change the answer: oral semaglutide · SURPASS-3. I have the document in front of me and I can read the numbers. What I cannot do is…
I have the full paper rather than the abstract, and the supplementary appendix. I can predict the outcome but I cannot explain it, which means I will get the next…
Numbers first: mazdutide · SELECT. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
What I am working with: orforglipron · REDEFINE-1. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
For reference: oral semaglutide · REDEFINE-1. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I…
Conditions: semaglutide · ATTAIN-1. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…